1

PLIVA, a Member of the Teva Group

Tihomir OreskovicPresident of the Management Board, Pliva Croatia Ltd.

October, 2013

Croatia & SEE

2

About TEVA – Strong Foundations

Over

46,000employees

73manufacturing

sites

111years in

existence

$20.3B2012 revenues

$5.352012 EPS

1,000molecules

60countries

70Btablets and

capsules per annum

55,000+SKUs

Croatia & SEE

3

Core Strenghts

3

Leading healthcare provider

Balanced business

model

IntegratedR&D

Manufacturing strengths

Partnering experience

Go-to-market capabilities

Entrepreneurial employees and

culture

Croatia & SEE

4

PLIVA in Croatia – Pharma Leader in SEE

PLIVA, a member of the Teva Group (since 2008).

Established in 1921

The largest pharmaceutical company in Croatia and one of the leading pharma companies in SEE

generics inovative products and therapies

(Copaxone...) regional partnerships

One of major exporters in Croatia >80% for export (30% Russia; 25% USA)

2000 employees in Croatia

Croatia & SEE

5

Working from Croatia

Over 60 locations worldwide

EU

RUSSIA

ASIAJAPAN

SAR

LATAM

USA

CANADA

Croatia & SEE

6

Croatia - Strategically Important Production Site for TEVA

New investment cycle in production• Teva is investing $200M+ in Croatia (2011 – 2014)• Significant expansion of production capacities in Zagreb• Construction of a new manufacturing plant and supporting facilities in Savski Marof

Vertically integrated production- highly sophisticated products

FDA approved - regularly audited by the FDA (since 1965), EMEA and other

Higly qualified employees• Knowledge and best

practice sharing

Croatia & SEE

7

Operations Croatia

$100M+ construction of Sterile and Oral Solid Forms facilitiesTechnology driven manufacturing siteSignificantly increased production capacities 80% for exportsCapacity 10B tabs

Complying with the highest global quality standards

Markets: US, EMIA, EU; >80% for export (30% Russia; 25% USA)

Croatia & SEE

8

TAPI Croatia - World’s Largest AZI Supplier

$100M+ the construction of the state-of-the-art facilitiesInvestment in integrated environmental protection ($20M) Supplying 90 % of AZI demand on regulated markets100 % increase in production capacities

Chemical development center (98% for exports)Markets: US, EMIA, EU, JP, CA, LATAM

Croatia & SEE

9

PLIVA’s R&D Center of Excellence

200+ highly skilled employees in R&DExperience and knowledge in development of complex projects Understanding of regulatory requirements: EU, US, CAN, EMIA, ASIA...One of the biggest users of the R&D tax incentives in Croatia

R&D Croatia - holder of Teva's strategy for the development of complex products and NTEs

Croatia & SEE

10

Beyond Production and R&D

Finance SSC

SSC Zagreb

Providing services to different sites/countries in EU, EMIA, Asia, Americas

IT SSCP

har

mak

ovi

gila

nce

Bu

sin

ess

dev

elo

pm

ent

Reg

ula

tory

HR

Leg

al

Co

mm

un

icat

ion

s

Pro

cuir

men

t

Qu

alit

yRegional &

Global support

Croatia & SEE

11

Working with Croatian Companies – Capabilities, Potentials and Opportunities

Croatia

• located in the heart of Central Europe

• the leading market for SEE region,

highly skilled and educated people

average salaries below the EU average

EU member July 2013

Competitive incentives, R&D, employment capital

Croatia & SEE

12Thank you!